150th World Health Organization Executive Board Meeting
Involvement of non-State actors in WHO’s governing bodies
Immunization Agenda 2030 & Infection prevention and control
The global health sector strategies & Road map for neglected tropical diseases 2021–2030
Strengthening WHO preparedness for and response to health emergencies
WHO’s implementation framework for Billion 3
Political declaration on the prevention and control of non-communicable diseases
Second Special Session of the World Health Assembly
74th World Health
Assembly
Public health, innovation and intellectual property, Falsified medical products medical devices nomenclature
Antimicrobial resistance & Immunization Agenda 2030
Prevention and Control of Non-Communicable Diseases & Medicines, Vaccines, and other health products
Implementation of the Global Strategy for Women’s, Children’s and Adolescents’ Health (2016−2030)
Health emergencies & Mental health preparedness for and response to the COVID-19 pandemic
WHO global strategy on health, environment and climate change
WHO Regional
Committee Sessions
of 2019
144th WHO EB
Meeting
WHO Regional
Committee Sessions
of 2018
Accreditation of regional non-State actors to the WHO Regional Committee for Europe
Action plan to improve public health preparedness and response in the WHO European Region
Advancing public health in the WHO European Region for sustainable development
Can people afford to pay for health care New evidence on financial protection in Europe
Countries at the centre the strategic role of country offices in the WHO European Region
Strategy on the health and well-being of men in the WHO European Region
World Health
Assembly 2018
Statement on Agenda Point 11.1: Draft thirteenth general programme of work 2019–2023
Statement on Agenda Point 11.2: Public health preparedness and response
Statement on Agenda Point 11.4: Health, environment and climate change
Statement on Agenda Point 12.2: Physical activity for health
Statement on Agenda Point 12.4: mHealth
Statement on Agenda Point 12.5: Improving access to assistive technology
Statement on Agenda Point 12.6: Maternal, infant and young child nutrition
World Health
Organization 142nd
Executive Board
Meeting
Statement Draft thirteenth general programme of work 2019–2023
Public health preparedness and response (with IVSA)
Health, environment and climate change
Addressing the global shortage of, and access to, medicines and vaccines
Preparation for a high-level meeting of the General Assembly on ending tuberculosis (with IVSA)
Global Platform for
Disaster Risk Reduction
2017
World Health
Assembly 2016
Statement on Maternal, Infant and Young Child Nutrition
Statement on WHO Response in Severe, Large-scale Emergencies
Statement on Promoting the Health of Migrants
Statement on 2014 Ebola Virus Disease Outbreak
Statement on Draft Global Strategies on HIV, STIs and Hepatitis 2016-2021
Statement on Substandard/Spurious/Falsely-labelled/Falsified/Counterfeit Medical Products
Statement on Prevention and Control of Non-communicable Diseases
Statement on Health in the 2030 Agenda for Sustainable Development
WHO Regional
Committee Sessions
of 2016
World Health
Organization 138th
Executive Board
Meeting
Statement on Agenda item: 5.5 – Framework of engagement with non-State actors
Statement on Agenda Item 6.1 – Maternal, infant and young child nutrition
Statement on Agenda Item 7.2 – Health in the 2030 Agenda for Sustainable Development
Statement on Agenda Item 8.5 – Global action plan on antimicrobial resistance